MYRIAD GENETICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
MYRIAD GENETICS, INC. (MYGN) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$394.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-24
- MYRIAD GENETICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$394.60M.
- MYRIAD GENETICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$125.40M.
- MYRIAD GENETICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$263.20M.
- MYRIAD GENETICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$141.30M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -$394.60M 10-K · filed 2026-02-24 | ||
| 2024-12-31 | -$125.40M 10-K · filed 2026-02-24 | ||
| 2023-12-31 | -$263.20M 10-K · filed 2026-02-24 | ||
| 2022-12-31 | -$141.30M 10-K · filed 2025-02-28 | ||
| 2021-12-31 | -$53.80M 10-K · filed 2024-02-28 | ||
| 2020-12-31 | -$101.80M 10-K · filed 2023-03-01 | ||
| 2020-06-30 | -$240.90M 10-K · filed 2023-03-01 | ||
| 2019-06-30 | -$600.00K 10-K · filed 2022-02-25 | ||
| 2018-06-30 | $122.30M 10-KT · filed 2021-03-16 | $119.10M 10-K · filed 2018-08-24 | |
| 2017-06-30 | $39.20M 10-K · filed 2019-08-13 | $45.90M 10-K · filed 2017-08-09 | |
| 2016-06-30 | $156.60M 10-K · filed 2018-08-24 | $169.50M 10-K · filed 2016-08-10 | |
| 2015-06-30 | $147.00M 10-K · filed 2017-08-09 | ||
| 2014-06-30 | $292.00M 10-K · filed 2016-08-10 | $292.08M 10-K · filed 2014-08-13 | |
| 2013-06-30 | $243.60M 10-K · filed 2015-08-12 | $243.56M 10-K · filed 2014-08-13 | |
| 2012-06-30 | $189.70M 10-K · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |